Transcript of Annual Meeting & Postgraduate Course
Naspghan Registration Brochure :Layout 1NOVEMBER 12–14, 2009
NATIONAL HARBOR, MD
Dear Colleague: We invite you to attend The NASPGHAN Annual Meeting
& Postgraduate Course to be held at the beautiful Gaylord
National Hotel in National Harbor, MD from Thursday through
Saturday November 12th –14th, 2009. The planning committee,
including B Li, John Barnard, John Pohl, Steven Schwarz, Alan
Leichtner, David Rudnick, Mitch Shub and Kathy Schwarz, has put
together an outstanding program that will engage the interest of
clinicians, academics, and trainees alike.
The NASPGHAN meeting will begin on Thursday November 12th, 2009
with the annual NASPGHAN Postgraduate Course. We will review a
broad spectrum of pediatric gastrointestinal physiology and
disease, testing, and treatment modalities. Five topics will be
available for this year’s course including obesity management,
advances in pediatric hepatobiliary disease, gastrointestinal
inflammation, treatment of functional abdominal pain, and new
diagnostic testing. Fifteen speakers from North America who are
experts in pediatric gastroenterology will present in-depth
discussions of these subjects, and we will have one-hour learning
lunches in which these speakers will present patient cases.
The main portion of the NASPGHAN meeting begins the evening of
Thursday November 12th with a poster session and reception and
concludes Saturday evening with a social event. An outstanding and
diverse faculty has been assembled for the meeting which will
include two distinguished invited speakers: Dr. Preston Campbell of
the Cystic Fibrosis Foundation and Dr. Stephen James, Director of
the NIDDK, state-of-the-art, year-in-review formats (for both
clinical and basic science), 6 research abstract oral presentations
and 3 poster sessions (covering basic science, clinical
investigation, and clinical practice vignettes and including oral
presentations of 6 Posters of Distinction on Friday and Saturday),
four concurrent clinical modules will include two new initiatives:
a “virtual” Hepatitis B session with 5 small discussion groups and
a multi-disciplinary team approach to the management of intestinal
failure. The clinical modules have been redesigned to include a
30-minute case-based panel and audience discussion.
Indeed, this year’s NASPGHAN Meeting will be a fabulous event, sure
to meet the multiple clinical, research and training needs of our
diverse membership.
We look forward to seeing you in our nation’s capital!
Cordially,
B Li, MD Kathleen Schwarz, MD President, NASPGHAN President-Elect,
NASPGHAN
ORGANIZING COMMITTEE B Li, MD (NASPGHAN President) . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . Program Advisor
David Gremse, MD (NASPGHAN Secretary-Treasurer) . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . Meeting budget
Sandeep Gupta, MD (Professional Education Committee) . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . Postgraduate
Course, Co-Director
Alan Leichtner, MD (Chair, Training Committee) . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . Teaching
and Tomorrow Program
Jenifer Lightdale, MD (Chair, Endoscopy Committee) . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . Video Learning Center
NASPGHAN National Office . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Meeting oversight, logistics, planning
John Pohl, MD (Chair, Professional Education Committee) . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . Postgraduate
Course, Co-Director
David Rudnick, MD (Chair, Research Committee) . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . Annual Meeting
Kathleen Schwarz, MD (NASPGHAN President-Elect) . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Program
Committee Chair
Steven Schwarz, MD (Chair, Clinical Care & Quality Committee) .
. . . Clinical Practice Forum, Clinical Vignette Posters, Billing
& Coding
Mitchell Shub, MD (Chair, Professional Development Committee) . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . Annual Meeting
Located just eight miles due south of Washington, DC, with
convenient access to three major airports, the resort hotel is just
15 minutes away from our nation's capital. Located in National
Harbor, Maryland in Prince George's County, Gaylord National offers
its guests convenient access to Washington, DC with an hourly
shuttle service, water taxi to Old Town Alexandria, and shuttle
service to Ronald Reagan National Airport.
HOTEL INFORMATION
GAYLORD NATIONAL® Convention Center 201 WATERFRONT STREET NATIONAL
HARBOR, MD 20745
HOTEL RESERVATIONS
Single/Double $239.00 + $15.00 Daily Resort Fee* *Includes: in-room
high speed internet access, local phone calls up
to 20 minutes, wireless internet access in atrium, lobby &
restaurants, toll-free phone calls up to 20 minutes, access to
fitness center, two bottled waters in guest room daily and a daily
newspaper.
Special NASPGHAN room rate. Applicable taxes will be added. (US
rate subject to change based on current exchange rates)
Check-in Time 3:00pm
Check-out Time 12:00noon
To obtain the special NASPGHAN room rates, register ONLINE via the
NASPGHAN website:
www.naspghan.org
REGISTRATION The DEADLINE for Early Bird Registration is August 1,
2009
To receive Early-Bird rates and submitting payment by check,
envelope must be postmarked no later than August 1, or standard
rates will apply.
After August 1st, Standard Rates are applicable. Fees for
Postgraduate Course and Annual Meeting will increase by $50 per
category.
The DEADLINE for Standard Registration is September 14, 2009
To receive Standard rates and submitting payment by check, envelope
must be postmarked no later than September 14, 2009, or On-site
registration rates will apply.
After September 14th, On-site Rates are applicable. Fees for
Postgraduate Course and Annual Meeting will increase by $50 per
category.
Register by mail, fax or Internet. Visit www.naspghan.org to
register online. Alternately, mail or fax the registration form
located on pages 15–17 of this brochure to the NASPGHAN National
Office. Meeting confirmations, tickets and badges will be mailed 3
weeks prior to the meeting.
MEETING OBJECTIVES AND CME INFORMATION Mission Statement
The education mission of the North American Society for Pediatric
Gastroenterology, Hepatology and Nutrition is to:
Advance understanding of normal development, physiology and
pathophysiology of diseases of the gastrointestinal tract, liver
and nutrition in children.
Improve professional competence, quality of care, and patient
outcomes by disseminating knowledge through scientific meetings,
professional and public education.
Our activities, education, and interventions will strive to use
Adult Learning Methods (ALM) designed to improve competence,
practice performance, and patient outcomes in measurable ways.
These educational activities will be targeted to board certified or
board eligible pediatric gastroenterologists, physicians with an
expertise in pediatric gastroenterology, hepatology and nutrition,
subspecialty fellows in pediatric gastroenterology, and nurses
specializing in pediatric gastroenterology, hepatology and
nutrition.
CME INFORMATION NASPGHAN is accredited by the Accreditation Council
for Continuing Medical Education to provide continuing medical
education for physicians. NASPGHAN designates this educational
activity for a maximum of 27.25 AMA PRA Category 1 Credit(s) TM.
(7.25 credit hours for the Postgraduate Course and 20.0 credit
hours for the Annual Meeting). Physicians should only claim credit
commensurate with the extent of their participation in the
activity.
FACULTY DISCLOSURE In order to ensure independence, objectivity and
scientific rigor in all activities and in accordance with the
ACCME, ANCC and ACPE Standards for Commercial Support, all those in
a position to control the content of an educational activity are
required to disclose their relevant financial relationships. This
includes indicating that one has nothing to disclose. Disclosure
information will be distributed to the activity attendees.
AMERICANS WITH DISABILITIES ACT In compliance with the Americans
with Disabilities Act of 1990, NASPGHAN will make all reasonable
effort to accommodate persons with disabilities. Contact NASPGHAN
in order to make arrangements.
NASPGHAN National Office PO Box 6 Flourtown, PA 19031
Telephone: 215-233-0808 Fax: 215-233-3918 Email:
naspghan@naspghan.org Website: www.naspghan.org
8:00am–8:10am INTRODUCTION
Course Directors: John Pohl MD and Sandeep Gupta MD
8:10am–9:20am MODULE A – Obesity: What Can We Do In The
Office?
Moderators: John Pohl MD and Kathy Chen MD
Evaluating obesity: Where do I start? Ann Scheimann MD, Johns
Hopkins School of Medicine
LEARNING OBJECTIVES:
1. Discuss how the obese child should be evaluated for
complications in the office setting, including the use of
laboratory testing 2. Define metabolic syndrome and its instability
as a diagnosis 3. Discuss current trials and possible use of
medication, combined with lifestyle change, including metformin
and
thiazolidinediones for treatment of steatohepatitis in association
with metabolic syndrome
Increasing activity: What can we do? Sarah Barlow MD, Texas
Children’s Hospital
LEARNING OBJECTIVES:
1. Summarize the determinants of increasing patient activity,
including behavior change and family-based changes 2. Discuss the
role of city/community exercise programs and exercise camps in
obesity management 3. Outline billing and insurance aspects
regarding these methods of weight reduction
Behavioral therapy and obesity Joseph Skelton MD, Wake Forest
University
LEARNING OBJECTIVES:
1. Discuss the role of behavioral modification in obesity
management and include strategies to improve clinician-family
interaction 2. Review the effectiveness of group visits to treat
pediatric obesity 3. Describe other psychological tools, including
motivational interviewing and readiness for change assessment
9:10am–9:20am Rapid Fire Questions
9:20am–10:30am MODULE B – Advances in Pediatric Liver Disease: How
Do We Interpret the Data?
Moderators: John Pohl MD and Vicky Ng MD
Alagille syndrome: Update Binita Kamath MD, Children’s Hospital of
Philadelphia
LEARNING OBJECTIVES:
1. Define Alagille syndrome and update the extra-hepatic
manifestations of this syndrome 2. Discuss genetic testing and
potential pre-natal testing for Alagille syndrome, including JAG1
and NOTCH2 mutations 3. Review the potential role of cholestatic
disease research consortia in the development of future diagnostic
testing and therapy
4
Mitochondrial liver disease: Amping up the liver Ronald Sokol MD,
University of Colorado
LEARNING OBJECTIVES:
1. Discuss the clinical presentations and genetics, including
extra-hepatic involvement, of mitochondrial liver disease 2. Review
current testing techniques (serum, hepatic tissue, muscle tissue,
CNS imagine, DNA testing, etc.) for mitochondrial
liver disease 3. Discuss pros and cons of liver transplantation in
mitochondrial diseases
Primary sclerosing cholangitis: Update Girish Subbarao MD, Indiana
University
LEARNING OBJECTIVES:
1. Discuss the pathophysiology of PSC and review its extra-hepatic
manifestations 2. Discuss the diagnosis of PSC, including liver
biopsy, MRCP, and ERCP, especially using these modalities to
differentiate PSC
from autoimmune hepatitis 3. Discuss PSC treatment, including high
dose versus standard dose ursodeoxycholic acid and liver
transplantation
10:20am–10:30am Rapid Fire Questions
10:30am–10:50am BREAK
10:50am–12:00pm MODULE C – Gastrointestinal Inflammation: What is
the Natural History of Disease?
Moderators: Sandeep Gupta MD and Miriam Vos MD
Eosinophilic esophagitis: making the eosinophils go away Richard
Noel MD, Medical College of Wisconsin
LEARNING OBJECTIVES:
1. Discuss the data available regarding the number of eosinophils
per high power field as it relates to treatment 2. Discuss
treatment of the pediatric patient in which eosinophilic
esophagitis is found incidentally 3. Discuss the natural history of
eosinophilic esophagitis as the pediatric patient progresses to
adulthood
H. pylori: Should it always be eradicated? Nicola Jones MD, The
Hospital for Sick Children, Toronto
LEARNING OBJECTIVES:
1. Discuss the treatment of a child with functional abdominal pain
symptoms in which H. pylori is found incidentally 2. Discuss when
H. pylori infection should undergo re-testing after a trial of
eradication 3. Discuss how a child with H. pylori should be treated
if there is no response to therapy
Inflammatory bowel disease and inflammatory markers Aleixo Muise
MD, The Hospital for Sick Children, Toronto
LEARNING OBJECTIVES:
1. Discuss what inflammatory markers are associated with severe IBD
in children 2. Discuss when genetic mutation testing should be used
in children with IBD and discuss potential future genetic testing
3. Discuss if inflammatory markers can change with therapy or with
mucosal healing
11:50am–12:00pmRapid Fire Questions
Session 1: Obesity and behavioral therapy
Moderator: Valeria Cohran MD Joseph Skelton MD
Session 2: Primary sclerosing cholangitis/ Elastometry and liver
disease
Moderator: Judy O’Connor MD Girish Subbarao MD and Marilyn Siegel
MD
Session 3: Alagille syndrome / Mitochondrial liver disease
Moderator: Vicky Ng MD Binita Kamath MD and Ronald Sokol MD
Session 4: Eosinophilic esophagitis / H. pylori infection
Moderator: Miriam Vos MD Richard Noel MD and Nicola Jones MD
Session 5: Biomarkers in IBD / MRI in gastrointestinal
disease
Moderator: Kevin Kelly MD Aleixo Muise MD and Ghassan Wahbeh
MD
Session 6: Hypnotherapy in irritable bowel syndrome / Inflammation
in irritable bowel syndrome
Moderator: Eyad Hanna MD Miranda Van Tilburg PhD and Robert Shulman
MD
Session 7: Metabolic syndrome and pharmacology / Exercise and
obesity
Moderator: Kathy Chen MD Ann Scheimann MD and Sarah Barlow MD
Session 8: Impedance monitoring / New medical therapies for
constipation
Moderator: Melanie Greifer MD Rachel Rosen MD and Rina Sanghavi
MD
1:50pm–3:00pm MODULE D – Treatment of Functional Abdominal
Pain
Moderators: John Pohl MD and Eyad Hanna MD
Hypnotherapy and irritable bowel syndrome Miranda Van Tilburg PhD,
University of North Carolina
LEARNING OBJECTIVES:
1. Discuss how hypnotherapy is a potential therapy for childhood
IBS and discuss what specific hypnotherapy techniques can be
utilized
2. Discuss the long-term outcome of hypnotherapy as treatment for
IBS 3. Review the clinical evidence that hypnotherapy is a
potential therapy for childhood IBS as well as an adjunctive use
with
medication
6
Irritable bowel syndrome and inflammation Robert Shulman MD, Texas
Children’s Hospital
LEARNING OBJECTIVES:
1. Discuss the theorized pathogenesis of inflammation in IBS 2.
Discuss studies that have shown a potential association of
intestinal inflammation with IBS 3. Discuss antibiotic treatment
options for IBS, in the setting of the potential for bacterial
overgrowth
New medical therapies for constipation Rina Sanghavi MD,
UT-Southwestern
LEARNING OBJECTIVES:
1. Discuss the use of lubiprostone for the treatment of
constipation 2. Discuss the potential use of bile acid therapy for
treatment of constipation 3. Discuss the potential use of pre- and
probiotics for the treatment of constipation
2:50pm–3:00pm Rapid Fire Questions
3:00pm–3:20pm BREAK
3:20pm–4:30pm MODULE E – New Diagnostic Modalities for
Gastrointestinal Disease
Moderators: Sandeep Gupta MD and Melanie Greifer MD
Impedance monitoring for GERD Rachel Rosen MD, Children’s Hospital,
Boston
LEARNING OBJECTIVES:
1. Discuss how impedance monitoring works and how it can be
combined with esophageal pH testing 2. Discuss how impedance
techniques can be used in evaluation of esophageal swallowing
function 3. Discuss the pediatric data available regarding
esophageal impedance studies
Elastometry imaging techniques of the liver Marilyn Siegel MD,
Washington University, St. Louis
LEARNING OBJECTIVES:
1. Discuss how elastometry is utilized in imaging as an alternative
to liver biopsy 2. Discuss the use of elastometry compared to other
invasive or non-invasive biomarkers in the diagnosis of
fibrosis/cirrhosis 3. Discuss the use of elastometry in the
evaluation of specific liver diseases, such as NAFLD or liver
disease associated with
congenital heart disease
LEARNING OBJECTIVES:
1. Review the advantages and disadvantages of MRI compared to other
types of abdominal imaging 2. Discuss medical radiation exposure
and its associated effects in children with IBD and how this risk
is alleviated with MRI 3. Discuss how MRI can be used to diagnose
intestinal/pelvic disease, including inflammatory bowel disease and
its complications
4:20pm–4:30pm Rapid Fire Questions
7
5:00pm–7:00pm Welcome Reception/Poster Session I
Friday, November 13, 2009 7:00am–8:00am Meet the Professor
Breakfasts (registration required)
1 Developmental biology research and pediatric gastrointestinal
diseases Robert Heukeroth MD,Washington University and Alan Mayer
MD, Medical College of Wisconsin
2 Treatment of HCV Jean Molleston MD, Indiana University and Girish
Subbaro MD, Indiana University
3 The difficult IBD patient Carmen Cuffari MD, Johns Hopkins School
of Medicine and Ryan Carvalho MD, Nationwide Children's
Hospital
4 Liver Disease in Inflammatory Bowel Disease Dennis Black MD, Le
Bonheur Children's Hospital and Tamir Miloh MD, Mt. Sinai School of
Medicine
5 Controversies in nutrition Maria Mascarenhas MD, Children’s
Hospital of Philadelphia and Susanna Huh MD, Children’s Hospital,
Boston
6 Functional Abdominal Pain: How much testing is really needed?
Samuel Nurko MD, MPH, Children’s Hospital Boston and Bruno
Chumpitazi MD, Texas Children’s Hospital
7 The GERD eQipp module and maintenance of certification Jenifer
Lightdale MD, Children’s Hospital Boston and Suzanne Nelson MD,
Northwestern University
7:00am–8:30am Clinical trials in pediatric gastroenterology
Patricia Robuck PhD, National Institute of Diabetes and Digestive
and Kidney Diseases
8:30am–10:00am Plenary Session I
Basic Science: Year in Review Eric Sibley MD, Stanford University,
Editor, JPGN
Award winning abstract presentations
Keynote Address–Building the CF Foundation Therapeutics Development
Program: Lessons Learned Preston Campbell MD, Executive Vice
President for Medical Affairs, Cystic Fibrosis Foundation,
Bethesda, MD
10:00am–10:30am Break
10:30am–12:00pm Concurrent Session I
A Virtual Hepatitis B Moderators: Maureen Jonas MD, Karen Murray
MD, Michael Narkewicz MD, Barbara Haber MD, Regino Gonzalez-Peralta
MD
Treatment of Hepatitis B Kathleen Schwarz MD, Johns Hopkins School
of Medicine
New Format–Kathy Schwarz will present a talk on the treatment of
children with hepatitis B. In order to facilitate small group
discussion the talk will be broadcast into 5 small rooms to
accommodate up to 30 persons each. A moderator skilled in the
treatment of hepatitis B, will lead a question and answer session
related to the virtual presentation. This is an experiment so
feedback is encouraged!
B Pancreatitis Moderators: Peter Durie MD and Sohail Husain
MD
Pancreatitis in childhood: Why, oh why? Veronique Morinville MD,
Montreal Children's Hospital
Acute pancreatitis: Dogmas and myths Mark Lowe MD, Children's
Hospital of Pittsburgh of UPMC
Chronic pancreatitis: Roadblocks on the long and windy road Patrick
Okolo MD, Johns Hopkins University
C Research Interest Group/Oral Abstract Presentations Moderators:
Robert Heukeroth MD and Elyanne Ratcliffe MD
Can Hirschsprung disease be prevented? New ideas from basic
research Robert Heukeroth MD, Washington University
12:15pm–2:15pm Poster Session II
2:30pm–4:00pm Concurrent Session II
A Acute Liver Failure Moderators: Will Treem MD and Kathleen
Campbell MD
Recognition/referral Robert Squires MD, Children's Hospital of
Pittsburgh of UPMC
Management Philip Rosenthal MD, University of California, San
Francisco
Outcomes Estella Alonso MD, Children's Memorial Hospital,
Chicago
B Gastrointestinal bleeding in pediatric patients: Why it happens
and how to make it stop Moderators: Marsha Kay MD and Mark Gilger
MD
Etiologies of GI bleeding in children Jenifer Lightdale MD,
Children’s Hospital, Boston
Medical management for upper gastrointestinal bleeding Khalid Khan
MD, University of Minnesota
Endoscopic therapy for UGI bleeding Douglas Fishman MD, Texas
Children’s Hospital
C Oral Abstract Presentations
Moderators: Steve Schwarz MD and Ian Leibowitz MD
Productivity and performance in pediatric GI practice: A view from
the dentist's chair Speakers: Michael Hart MD, Kathleen Mueller and
Robert Squires MD
6:00pm–8:00pm Training Program Directors Meeting
Saturday, November 14, 2009
7:00am–8:00am Meet the Professor Breakfasts (Registration
Required)
1 Translational research in pediatric gastroenterology James Heubi
MD Cincinnati Children’s Hospital & Medical Center and Glenn
Furuta MD, The Children’s Hospital, Denver
2 Psychological issues of IBD Eva Szigethy MD, PhD, Children’s
Hospital, Boston and Christine Karkowski MD, Children's Hospital of
Pittsburgh of UPMC
3 Food allergy Philip Putnam MD, Cincinnati Children’s Hospital
& Medical Center and J Pablo Abonia MD, Cincinnati Children’s
Hospital & Medical Center
4 GI infections Michael Farrell MD, Cincinnati Children’s Hospital
& Medical Center and Sean Moore MD, Vanderbilt Children’s
Hospital
5 Endoscopic research Bradley Barth MD, Children’s Medical Center
of Dallas and Tom Lin MD, Duke University Medical Center
6 Animal models of inflammatory bowel disease Ted Denson MD
Cincinnati Children’s Hospital & Medical Center and Edwin De
Zoeten MD, Children’s Hospital of Philadelphia
7:00am–8:30am IBD research: A guide for fellows and junior
faculty
1 Subra Kugathasan MD, Emory University
2 Ying Lu MD, Children’s Hospital, Boston
3 Athos Bousvaros MD, Children’s Hospital, Boston
4 Michael Kappelman MD, University of North Carolina
5 Marjorie Merrick, Crohn's & Colitis Foundation of
America
6 Sandra Kim MD, Crohn's & Colitis Foundation of America
10
8:30am–10:00am Plenary Session II
Clinical Science: Year in Review William Balistreri MD, Cincinnati
Children’s Hospital and Medical Center, Editor, Pediatrics
Maintenance of Certification and Quality Improvement Chris
Dickinson MD, American Board of Pediatrics Richard Colletti MD,
Trailblazer Improvement Collaborative
Oral Abstract Presentations
Moderators: Harpreet Pall MD and Leo Heitlinger MD Kathleen
Mueller
10:00am–12:00pm Poster Session III
12:00pm–2:00pm Annual Business Meeting/Lunch
Keynote Address–NIDDK Support of Research in Pediatric
Gastroentology, Hepatology and Nutrition Stephen James MD, Director
of The National Institute of Diabetes and Digestive and Kidney
Diseases (NIDDK)
2:00pm–3:30pm Concurrent Session III
A Guidelines Moderators: Steven Schwarz MD and Pamela Brown
MD
Probiotics David Mack MD, Children's Hospital of Eastern
Ontario
Neurodevelopmental Kay Motil MD, Baylor University
Skeletal health and IBD Helen Pappas MD, Children’s Hospital,
Boston
B Intestinal Failure: The importance of a team approach to problem
solving from intestinal rehabilitation to transplantation and
beyond Moderator: Stuart Kaufman MD
Intestinal Rehabilitation Surgeon Alfred Chahine MD, Georgetown
University School of Medicine
Nurse Coordinator Jill I. Robinson RN, BSN, PNP, Georgetown
University School of Medicine
Nutritionist Paige Parady RD, Georgetown University School of
Medicine
Pediatric Gastroenterologist Team Leader Stuart S. Kaufman MD,
Georgetown University School of Medicine
Social Worker Carrie Potoff MSW, LICSW, Georgetown University
School of Medicine
Surgical Nurse Coordinator Martha Kossairas RN, BSN, Georgetown
University School of Medicine
Transplant Surgeon Cal S. Matsumoto MD
C Oral Abstract Presentations
3:45pm–5:15pm Concurrent Session IV
A IBD – Biologics Moderators: Athos Bousvaros MD and Maria
Oliva–Hemker MD
TNF Inhibitors: Update on efficacy and safety Wallace Crandall MD,
Nationwide Children’s Hospital
When should you consider early use of biologics? Joel Rosh MD,
Goryeb Children’s Hospital
Beyond TNF Inhibitors: New biologics and the new wave of IBD
therapeutics Robert Baldassano MD, Children’s Hospital of
Philadelphia
B Celiac Disease Moderators: Alan Leichtner MD and Murali Jatla
MD
Diagnosis/Markers Ivor Hill MD, Wake Forest University
Long term complications Ed Hoffenberg MD, The Children’s Hospital,
Denver
New therapies Alessio Fasano MD, University of Maryland
C Oral Abstract Presentations
Program Description:
This year's meeting will highlight a multidisciplinary approach to
pediatric gastroenterolgy, hepatology and nutrition-related
problems. Selected topics include advocacy for children with
Inflammatory Bowel Disease, Treatment of IBD with Biologics, Fatty
Liver Disease, Intestinal Failure, Functional Abdominal Pain,
Failure to Thrive, Vitamin D and Inflammation.
Concurrent sessions on Gastrostomy Tubes, NP postgraduate
educational requirements, Endoscopy and Interpretation of lab
(liver) tests will be presented. We will also have case
presentations (Zebras) by social workers, physician assistants,
dieticians, occupational therapists and nurses as well as abstract
presentations.
We will hold an allied health professionals networking luncheon for
all attendees and a social event to celebrate APGNN's 20th
Anniversary.
FRIDAY, NOVEMBER 13, 2009
8:15am–9:00am KEYNOTE ADDRESS: ADVOCACY FOR CHILDREN WITH
INFLAMMATORY BOWEL DISEASE Jennifer Jaff, Esq.
9:00am–9:40am BIOLOGICS AND BEYOND Athos Bousvaros MD
9:40am–10:00am BREAK
11:45am–1:00pm NETWORKING LUNCHEON
2:15pm–2:30pm BREAK
2:30pm–4:00pm DIFFERENT POINTS OF VIEW: INTERESTING CASES PRESENTED
BY MULTIPLE DISCIPLINES Moderator: Mary Alice Tully, MSN,
PNP-BC
Amanda Leonard, MPH, RD, CDE Jody Weckwerth, PA Janice Tendler, RN,
MS, CPNP Saundra Carpenter, RN Janice Arnold, LICSW Linda
Schuberth, MA, OTR/L, SCFES
4:30pm COMMITTEE MEETINGS
13
8:00am BREAKFAST/REGISTRATION
8:15am–9:45am FAILURE TO THRIVE LeAnne Vitito, MS, APRN, CGRN
Jenifer Hampsey, MS, RD, CSP Maureen Lefton-Greif, PhD, CCC-SLP,
BRS-S
9:45am–10:00am BREAK
10:00am–10:45am VITAMIN D, IBD AND INFLAMMATION Helen Pappa
MD
10:45am–12:00pm POSTER PRESENTATIONS
AWARD PRESENTATIONS Poster of Distinction Award CDHNF/APGNN M.
Susan Moyer Nursing Research Award APGNN Excellence in Education
Award APGNN Excellence in Mentoring Award APGNN Newsletter
Award
12:00pm–2:00pm NASPGHAN BUSINESS LUNCH
2:00pm–3:30pm INTESTINAL FAILURE (JOINT SESSION WITH NASPGHAN)
Moderator: Stuart Kaufman MD
3:30pm–4:00pm BREAK
4:00pm–5:00pm CONCURRENT SESSIONS
1. NP ROUNDTABLE Moderator: Robin Shannon, MSN, RNC, PNP Discussion
of New Educational Requirements Sharon Dudley-Brown, PhD &
Jennifer Hill, DNP, ARNP
2. GASTROSTOMY TUBES Susanne Johnson, MSN, APRN
3. ENDOSCOPY ROUNDTABLE Lisa Heard, BSN, RN, CGRN
4. INTERPRETATION OF LAB (LIVER)TESTS TBA
14
REGISTRATION FORM
November 12–14 , 2009 Early-Bird Registration Deadline: August 1,
2009
(To receive Early-Bird rates, envelopes must be postmarked no later
than August 1, or standard rates will apply) After August 1st,
Standard Rates are applicable. Fees for Postgraduate Course and
Annual Meeting will increase by $50
per category. Register on-line at (www.naspghan.org) Please fill in
below information completely. Address must indicate where
registration/meeting material should be sent.
First Name Last Name
NASPGHAN Postgraduate Course (Thursday, November 12, 2009)
Check your member type Early Bird Rates Standard Rates Amount owed
Deadline 8/1/09** Deadline 9/14/09
Member A $300 $350
Non-member B $400 $450
Allied Health Professional G $225 $275
Student / Resident H $75 $125
** To receive Early-Bird rates, envelopes must be postmarked no
later than August 1, or standard rates will apply
NASPGHAN Postgraduate Course Learning Lunches(Select One)
(Thursday, November 12, 2009) You must be registered for the PG
Course to attend a Learning Lunch
Learning Lunches ($50) Amount owed See Page 6 for titles and
indicate by number below
First Choice:
Second Choice:
Third Choice:
NASPGHAN Annual Meeting (November 12–14, 2009)
Check your member type Early Bird Rates Standard Rates Amount owed
Deadline 8/1/09** Deadline 9/14/09
Member I $325 $375
Non-member J $500 $550
Allied Health Professional O $275 $325
Student / Resident P $75 $125
** To receive Early-Bird rates, envelopes must be postmarked no
later than August 1, or standard rates will apply
Additional Events (Friday, November 13 & Saturday, November 14,
2009) Indicate all choices Fee Amount owed
Billing and Coding (Saturday) U No Charge
Meet the Professor Breakfast W1 $40 (Friday) See Page 8 Indicate
Choice Below
Meet the Professor Breakfast W2 $40 (Saturday) See Page 10 Indicate
Choice Below
Extra Tickets for Saturday X $75Social (Adults)
Extra Tickets for Saturday Y $20Social (Child)
TOTAL $
Meet the Professor Breakfast Sessions (Friday, November 13 &
Saturday, November 14, 2009) See page 8 (Friday Sessions) or page 9
(Saturday Sessions) and indicate choices BY NUMBERS below
Friday, November 13, 2009 Saturday, November 14, 2009
First Choice: First Choice:
Second Choice: Second Choice:
Third Choice: Third Choice:
Payment Information: MasterCard Visa
Credit Card #:_______________________________________Verification
Code #:_________ Expiration Date:_________________
Make checks (drawn on a US bank in US funds) payable to NASPGHAN
(Mail or Fax completed form to): NASPGHAN / PO Box 6 / Flourtown,
PA 19031 Fax: 215-233-3918
Contact NASPGHAN National Office if further information is needed
Phone: 215-233-0808 / Fax: 215-233-3918 / naspghan@naspghan.org /
www.naspghan.org
NASPGHAN ID 84-126-4996
NASPGHAN Postgraduate Course – Registration fees include
Postgraduate course syllabus, continental breakfast, and coffee
breaks
NASPGHAN Annual Meeting – Registration fees for the Annual Meeting
include the wine and cheese reception on Thursday evening,
continental breakfast on Saturday morning, lunch on Friday and
Saturday, coffee breaks, and the Social event on Saturday
evening.
Cancellation and Refund:
Requests for refunds must be submitted in writing and be received
in the National Office by October 14, 2009. No refund requests will
be accepted after that date. Registration badge and receipt must
accompany request. Approved refunds will be issued after the
meeting.
Booth Selection (NASPGHAN reserves the right to rearrange the floor
plan or relocate displays)
17